The high sales highlight both the drug’s adoption and the rising incidence of cancer in India, a TOI report stated. Over 3,100 new brands were introduced during the year, collectively ...

GSK has announced a 50/50 joint venture with ... six-in-one combination paediatric vaccine to help protect children in India and other developing countries from polio and other infectious diseases.

GSK is to spend over US $1 billion to increase its stakes in its consumer healthcare subsidiaries in India and Nigeria. GSK will increase its share of its publicly-listed Consumer Healthcare ...

GSK Pharma board approves sale of Vemgal plant ... its global pipeline in areas like respiratory drugs and vaccines in India. Apex Labs pioneered the introduction of zinc-based formulations ...

India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday ...

(Reuters) - India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin. The Indian ...